Holotranscobalamin Remains Unchanged During Pregnancy
1 other identifier
observational
150
1 country
1
Brief Summary
Background and objective: Plasma cobalamins decrease during pregnancy but it is not fully elucidated how this is reflected in the total and cobalamin saturated transport proteins, transcobalamin (total TC, holoTC) and haptocorrin (total HC, holoHC). TC transports cobalamin into the cells. The function of HC is unknown, but in contrast to TC it binds both cobalamins and cobalamin analogues. Design and methods: Healthy pregnant women (N=141) had blood samples drawn at 18th, 32nd, 39th gestation week and 8 weeks postpartum. The protein moiety of TC and HC (total and holo) was measured by in-house ELISA methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 1995
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1995
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 1997
CompletedFirst Submitted
Initial submission to the registry
April 27, 2007
CompletedFirst Posted
Study publicly available on registry
April 30, 2007
CompletedOctober 17, 2008
April 1, 2007
April 27, 2007
October 16, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Danish healthy Caucasian women \>18 years of age with previous uncomplicated pregnancies and deliveries and presently with a normal pregnancy.
You may not qualify if:
- \>4 cigarettes smoked per day,
- Treatment with vitamin B12, folic acid or acetyl salicylic acid,
- Impaired renal function and clinically significant vaginal haemorrhage before first visit as well as blood haemoglobin \<6.4 mmol/L at first visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- University of Copenhagencollaborator
Study Sites (1)
Nils Milman
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nils Milman, MD
University of Copenhagen
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 27, 2007
First Posted
April 30, 2007
Study Start
January 1, 1995
Study Completion
December 1, 1997
Last Updated
October 17, 2008
Record last verified: 2007-04